Morbidity and mortality of deep sedation in outpatient bone marrow biopsy

Christopher M. Burkle, Barry A. Harrison, Lisa F. Koenig, Paul A. Decker, David Oman Warner, Dennis A. Gastineau

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Deep sedation is being provided at an increasing rate for patients undergoing bone marrow biopsy and aspiration (BMBA). The aim of this study was to establish the safety of deep sedation used for adults undergoing BMBA. A nonrandomized database analysis and retrospective review of patient records from January 1997 to December 2000 was performed; 5,811 patients were identified as having undergone their first outpatient BMBA. Outcome measures included 30-day mortality and same-day hospital admission; surrogate measures included need for a surgical procedure or receipt of red blood cells within the 48 hr following the BMBA. Patients who received intravenously administered midazolam, fentanyl, and propofol for maintenance of deep sedation plus infiltration of a local anesthetic (n = 2,604; 45%) comprised the deep sedation group; those who received infiltration of a local anesthetic but no intravenous sedation or analgesia (n = 3,207; 55%) comprised the local anesthesia group. Patients in the deep sedation group compared to those in the local anesthesia group were less likely to die within 30 days (0.69% vs. 1.34%, P = 0.018) and less likely to receive red blood cells (1.27% vs. 2.25%, P = 0.006). No other differences between the groups were found. Although the study was retrospective and nonrandomized, the results suggest that the use of deep sedation for outpatient BMBA is as safe as using local anesthesia.

Original languageEnglish (US)
Pages (from-to)250-256
Number of pages7
JournalAmerican Journal of Hematology
Volume77
Issue number3
DOIs
StatePublished - Nov 2004

Fingerprint

Deep Sedation
Needle Biopsy
Outpatients
Bone Marrow
Morbidity
Biopsy
Mortality
Local Anesthesia
Local Anesthetics
Erythrocytes
Midazolam
Fentanyl
Propofol
Analgesia
Retrospective Studies
Maintenance
Outcome Assessment (Health Care)
Databases
Safety

Keywords

  • Anesthesiology
  • Bone marrow biopsy
  • Hematology

ASJC Scopus subject areas

  • Hematology

Cite this

Burkle, C. M., Harrison, B. A., Koenig, L. F., Decker, P. A., Warner, D. O., & Gastineau, D. A. (2004). Morbidity and mortality of deep sedation in outpatient bone marrow biopsy. American Journal of Hematology, 77(3), 250-256. https://doi.org/10.1002/ajh.20185

Morbidity and mortality of deep sedation in outpatient bone marrow biopsy. / Burkle, Christopher M.; Harrison, Barry A.; Koenig, Lisa F.; Decker, Paul A.; Warner, David Oman; Gastineau, Dennis A.

In: American Journal of Hematology, Vol. 77, No. 3, 11.2004, p. 250-256.

Research output: Contribution to journalArticle

Burkle, CM, Harrison, BA, Koenig, LF, Decker, PA, Warner, DO & Gastineau, DA 2004, 'Morbidity and mortality of deep sedation in outpatient bone marrow biopsy', American Journal of Hematology, vol. 77, no. 3, pp. 250-256. https://doi.org/10.1002/ajh.20185
Burkle, Christopher M. ; Harrison, Barry A. ; Koenig, Lisa F. ; Decker, Paul A. ; Warner, David Oman ; Gastineau, Dennis A. / Morbidity and mortality of deep sedation in outpatient bone marrow biopsy. In: American Journal of Hematology. 2004 ; Vol. 77, No. 3. pp. 250-256.
@article{a37567411bd14d03ae3da2218dbf4251,
title = "Morbidity and mortality of deep sedation in outpatient bone marrow biopsy",
abstract = "Deep sedation is being provided at an increasing rate for patients undergoing bone marrow biopsy and aspiration (BMBA). The aim of this study was to establish the safety of deep sedation used for adults undergoing BMBA. A nonrandomized database analysis and retrospective review of patient records from January 1997 to December 2000 was performed; 5,811 patients were identified as having undergone their first outpatient BMBA. Outcome measures included 30-day mortality and same-day hospital admission; surrogate measures included need for a surgical procedure or receipt of red blood cells within the 48 hr following the BMBA. Patients who received intravenously administered midazolam, fentanyl, and propofol for maintenance of deep sedation plus infiltration of a local anesthetic (n = 2,604; 45{\%}) comprised the deep sedation group; those who received infiltration of a local anesthetic but no intravenous sedation or analgesia (n = 3,207; 55{\%}) comprised the local anesthesia group. Patients in the deep sedation group compared to those in the local anesthesia group were less likely to die within 30 days (0.69{\%} vs. 1.34{\%}, P = 0.018) and less likely to receive red blood cells (1.27{\%} vs. 2.25{\%}, P = 0.006). No other differences between the groups were found. Although the study was retrospective and nonrandomized, the results suggest that the use of deep sedation for outpatient BMBA is as safe as using local anesthesia.",
keywords = "Anesthesiology, Bone marrow biopsy, Hematology",
author = "Burkle, {Christopher M.} and Harrison, {Barry A.} and Koenig, {Lisa F.} and Decker, {Paul A.} and Warner, {David Oman} and Gastineau, {Dennis A.}",
year = "2004",
month = "11",
doi = "10.1002/ajh.20185",
language = "English (US)",
volume = "77",
pages = "250--256",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Morbidity and mortality of deep sedation in outpatient bone marrow biopsy

AU - Burkle, Christopher M.

AU - Harrison, Barry A.

AU - Koenig, Lisa F.

AU - Decker, Paul A.

AU - Warner, David Oman

AU - Gastineau, Dennis A.

PY - 2004/11

Y1 - 2004/11

N2 - Deep sedation is being provided at an increasing rate for patients undergoing bone marrow biopsy and aspiration (BMBA). The aim of this study was to establish the safety of deep sedation used for adults undergoing BMBA. A nonrandomized database analysis and retrospective review of patient records from January 1997 to December 2000 was performed; 5,811 patients were identified as having undergone their first outpatient BMBA. Outcome measures included 30-day mortality and same-day hospital admission; surrogate measures included need for a surgical procedure or receipt of red blood cells within the 48 hr following the BMBA. Patients who received intravenously administered midazolam, fentanyl, and propofol for maintenance of deep sedation plus infiltration of a local anesthetic (n = 2,604; 45%) comprised the deep sedation group; those who received infiltration of a local anesthetic but no intravenous sedation or analgesia (n = 3,207; 55%) comprised the local anesthesia group. Patients in the deep sedation group compared to those in the local anesthesia group were less likely to die within 30 days (0.69% vs. 1.34%, P = 0.018) and less likely to receive red blood cells (1.27% vs. 2.25%, P = 0.006). No other differences between the groups were found. Although the study was retrospective and nonrandomized, the results suggest that the use of deep sedation for outpatient BMBA is as safe as using local anesthesia.

AB - Deep sedation is being provided at an increasing rate for patients undergoing bone marrow biopsy and aspiration (BMBA). The aim of this study was to establish the safety of deep sedation used for adults undergoing BMBA. A nonrandomized database analysis and retrospective review of patient records from January 1997 to December 2000 was performed; 5,811 patients were identified as having undergone their first outpatient BMBA. Outcome measures included 30-day mortality and same-day hospital admission; surrogate measures included need for a surgical procedure or receipt of red blood cells within the 48 hr following the BMBA. Patients who received intravenously administered midazolam, fentanyl, and propofol for maintenance of deep sedation plus infiltration of a local anesthetic (n = 2,604; 45%) comprised the deep sedation group; those who received infiltration of a local anesthetic but no intravenous sedation or analgesia (n = 3,207; 55%) comprised the local anesthesia group. Patients in the deep sedation group compared to those in the local anesthesia group were less likely to die within 30 days (0.69% vs. 1.34%, P = 0.018) and less likely to receive red blood cells (1.27% vs. 2.25%, P = 0.006). No other differences between the groups were found. Although the study was retrospective and nonrandomized, the results suggest that the use of deep sedation for outpatient BMBA is as safe as using local anesthesia.

KW - Anesthesiology

KW - Bone marrow biopsy

KW - Hematology

UR - http://www.scopus.com/inward/record.url?scp=7244234133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7244234133&partnerID=8YFLogxK

U2 - 10.1002/ajh.20185

DO - 10.1002/ajh.20185

M3 - Article

VL - 77

SP - 250

EP - 256

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 3

ER -